A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes

Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma‐like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously...